Page 97

House Bill No. 5506

Public Act No. 22-118 97 of 739

(6) "Device" has the same meaning as provided in section 20-571; (7) "Pharmacist" has the same meaning as provided in section 20-571; (8) "Prescribing practitioner" has the same meaning as provided in section 20-571; (9) "Provider-patient relationship" means a relationship between a prescribing practitioner and a patient in which (A) the patient has made a medical complaint, (B) the patient has provided such patient's medical history, (C) the patient has received a physical examination, and (D) there exists a logical connection between such medical complaint, medical history and physical examination and any drug or device prescribed for such patient; and (10) "Qualified pharmacist" means a pharmacist who (A) is deemed competent under regulations adopted by the commissioner pursuant to subsection (e) of this section, and (B) has reviewed the latest edition of the "Pharmacists' Patient Care Process" published by the Joint Commission of Pharmacy Practitioners. [(a)] (b) Except as provided in section 20-631b, one or more qualified pharmacists [licensed under this chapter who are determined competent in accordance with regulations adopted pursuant to subsection (d) of this section] may enter into a [written protocol-based] collaborative drug therapy management agreement [with one or more physicians licensed under chapter 370 or advanced practice registered nurses licensed under chapter 378 to] or manage the drug therapy of, and devices prescribed to, individual patients, or a patient population, under a collaborative drug therapy management policy. In order to enter into a [written protocol-based] collaborative drug therapy management agreement [, such physician or advanced practice registered nurse shall have established] or collaborative drug therapy care plan, or operate under a collaborative drug therapy management